From teratocarcinomas to embryonic stem cells and beyond: A history of embryonic stem cell research

Nature Reviews Genetics

Volumn 7, Issue 4, 2006, Pages 319-327

  Solter, Davor ^a  

^a MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ANIMAL CELL; CELL DIFFERENTIATION; CLONING; DEGENERATIVE DISEASE; EMBRYO; EMBRYONIC STEM CELL; HUMAN; HUMAN CELL; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; REPRODUCTION; REVIEW; TERATOCARCINOMA; TERATOMA;

ANIMALS; EMBRYO; EMBRYO RESEARCH; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MALE; MICE; STEM CELLS; TERATOCARCINOMA; TESTICULAR NEOPLASMS;

ANIMALIA;

EID: 33645113300     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg1827     Document Type: Review

References (118)

1. Stevens, L. C. Jr & Little, C. C. Spontaneous testicular teratomas in an inbred strain of mice. Proc. Natl Acad. Sci. USA 40, 1080-1087 (1954).
2. Stevens, L. C. Experimental production of testicular teratomas in mice. Proc. Natl Acad. Sci. USA 52, 654-661 (1964).
3. Kleinsmith, L. J. & Pierce, G. B. Jr. Multipotentiality of single embryonal carcinoma cells. Cancer Res. 24, 1544-1551 (1964).
4. Solter, D., Skreb, N. & Damjanov, I. Extrauterine growth of mouse egg-cylinders results in malignant teratoma. Nature 227, 503-504 (1970).
5. Stevens, L. C. The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryos. Dev. Biol. 21, 364-382 (1970).
6. Stevens, L. C. A new inbred subline of mice (129/terSv) with a high incidence of spontaneous congenital testicular teratomas. J. Natl Cancer Inst. 50, 235-242 (1973).
7. Youngren, K. K. et al. The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours. Nature 435, 360-364 (2005).
8. Stevens, L. C. & Varnum, D. S. The development of teratomas from parthenogenetically activated ovarian mouse eggs. Dev. Biol. 37, 369-380 (1974).
9. Pierce, G. B., Verney, E. L. & Dixon, F. J. The biology of testicular cancer. I. Behavior after transplantation. Cancer Res. 17, 134-138 (1957).
10. Sherman, M. I. & Solter, D. (eds) Teratomas and Differentiation (Academic Press, New York, 1975).
11. Pierce, G. B. & Verney, E. L. An in vitro and in vivo study of differentiation in teratocarcinomas. Cancer 14, 1017-1029 (1961).
12. Rosenthal, M. D., Wishnow, R. M. & Sato, G. H. In vitro growth and differentiation of clonal populations of multipotential mouse cells derived from a transplantable testicular teratocarcinoma. J. Natl Cancer Inst. 44, 1001-1014 (1970).
13. Kahan, B. W. & Ephrussi, B. Developmental potentialities of clonal in vitro cultures of mouse testicular teratoma. J. Natl Cancer Inst. 44, 1015-1029 (1970).
14. Evans, M. J. The isolation and properties of a clonal tissue culture strain of pluripotent mouse teratoma cells. J. Embryol. Exp. Morph. 28, 163-176 (1972).
15. Jakob, H., Boon, T., Gaillard, J., Nicolas, J.-F. & Jacob, F. Tératocarcinome de la souris: Isolement, culture et proprié tés de cellules à potentialités multiples. Ann. Microbiol. (Paris) 124, 269-282 (1973) (in French).
16. Nicolas, J. F., Dubois, P., Jakob, H., Gaillard, J. & Jacob, F. Tératocarcinome de la souris: différenciation en culture d'une lignée de cellules primitives à potentialités multiples. Ann. Microbiol. (Paris) 126, 3-22 (1975) (in French).
17. Martin, G. R. & Evans, M. J. The morphology and growth of a pluripotent teratocarcinoma cell line and its derivatives in tissue culture. Cell 2, 163-172 (1974).
18. Martin, G. R. & Evans, M. J. Differentiation of clonal lines of teratocarcinoma cells: Formation of embryoid bodies in vitro. Proc. Natl Acad. Sci. USA 72, 1441-1445 (1975).
19. Martin, G. R. & Evans, M. J. Multiple differentiation of clonal teratocarcinoma stem sells following embryoid body formation in vitro. Cell 6, 467-474 (1975).
20. Martin, G. R. Teratocarcinomas as a model system for the study of embryogenesis and neoplasia. Cell 5, 229-243 (1975).
21. Fogh, J. & Trempe, G. in Human Tumor Cells In Vitro (ed. Fogh, J.) 115-159 (Plenum, New York, 1975).
22. Hogan, B., Fellous, M., Avner, P. & Jacob, F. Isolation of a human teratoma cell line which expresses F9 antigen. Nature 270, 515-518 (1977).
23. Andrews, P. W., Bronson, D. L., Benham, F., Strickland, S. & Knowles, B. B. A comparative study of eight cell lines derived from human testicular teratocarcinoma. Int. J. Cancer 26, 269-280 (1980).
24. Andrews, P. W., Goodfellow, P. N., Shevinsky, L. H., Bronson, D. L. & Knowles, B. B. Cell-surface antigens of a clonal human embryonal carcinoma cell line: morphological and antigenic differentiation in culture. Int. J. Cancer 29, 523-531 (1982).
25. Andrews, P. W. et al. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line tera-2. Lab. Invest. 50, 147-162 (1984).
26. Lee, V. M.-Y. & Andrews, P. W. Differentiation of NTERA-2 clonal human embryonal carcinoma cells into neurons involves the induction of all three neurofilament proteins. J. Neurosci. 6, 514-521 (1986).
27. Andrews, P. W., Goodfellow, P. N. & Damjanov, I. Human teratocarcinoma cells in culture. Cancer Surv. 2, 41-73 (1983).
28. Andrews, P. W. From teratocarcinomas to embryonic stem cells. Phil. Trans. R. Soc. Lond. B 357, 405-417 (2002).
29. Bernstine, E. G., Hooper, M. L., Grandchamp, S. & Ephrussi, B. Alkaline phosphatase activity in mouse teratoma. Proc. Natl Acad. Sci. USA 70, 3899-3903 (1973).
30. Benham, F. J., Andrews, P. W., Knowles, B. B., Bronson, D. L. & Harris, H. Alkaline phosphatase isozymes as possible markers of differentiation in human testicular teratocarcinoma cell lines. Dev. Biol. 88, 279-287 (1981).
31. Stern, P. L. et al. Monoclonal antibodies as probes for differentiation and tumor-associated antigens: a Forssman specificity on teratocarcinoma stem cells. Cell 14, 775-783 (1978).
32. Solter, D. & Knowles, B. B. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc. Natl Acad. Sci. USA 75, 5565-5569 (1978).
33. Gooi, H. C. et al. Stage-specific embryonic antigen involves α1→3 fucosylated type 2 blood group chains. Nature 292, 156-158 (1981).
34. Shevinsky, L. H., Knowles, B. B., Damjanov, I. & Solter, D. Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell 30, 697-705 (1982).
35. Kannagi, R. et al. Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J. 2, 2355-2361 (1983).
36. Kannagi, R. et al. New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3. J. Biol. Chem. 258, 8934-8942 (1983).
37. Fenderson, B. A., Andrews, P. W., Nudelman, E., Clausen, H. & Hakomori, S.-I. Glycolipid core structure switching from globo- to lacto- and ganglio-series during retinoic acid-induced differentiation of TERA-2-derived human embryonal carcinoma cells. Dev. Biol. 122, 21-34 (1987).
38. Henderson, J. K. et al. Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. Stem Cells 20, 329-337 (2002).
39. Strickland, S. & Mahdavi, V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 15, 393-403 (1978).
40. Jakob, H., Dubois, P., Eisen, H. & Jacob, F. Effets de l'hexaméthylènebisacétamide sur la différenciation de cellules de carcinome embryonnaire. C. R. Acad. Sci. Hebd. Seances Acad. Sci. D 286, 109-111 (1978) (in French).
41. Andrews, P. W. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol. 103, 285-293 (1984).
42. Simeone, A. et al. Sequential activation of HOX2 homeobox genes by retinoic acid in human embryonal corcinoma cells. Nature 346, 763-66 (1990).
43. Brinster, R. L. The effect of cells transferred into the mouse blastocyst on subsequent development. J. Exp. Med. 140, 1049-1056 (1974).
44. Mintz, B. & Illmensee, K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Natl Acad. Sci. USA 72, 3585-3589 (1975).
45. Illmensee, K. & Mintz, B. Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts. Proc. Natl Acad. Sci. USA 73, 549-553 (1976).
46. Stewart, T. A. & Mintz, B. Successive generations of mice produced from an established culture line of euploid teratocarcinoma cells. Proc. Natl Acad. Sci. USA 78, 6314-6318 (1981).
47. Stewart, T. A. & Mintz, B. Recurrent germ-line transmission of the teratocarcinoma genome from the METT-1 culture line to progeny in vivo. J. Exp. Zool. 224, 465-469 (1982).
48. Papaioannou, V. E., McBurney, M. W., Gardner, R. L. & Evans, M. J. Fate of teratocarcinoma cells injected into early mouse embryos. Nature 258, 70-73 (1975).
49. Papaioannou, V. E., Gardner, R. L., McBurney, M. W., Babinet, C. & Evans, M. J. Participation of cultured teratocarcinoma cells in mouse embryogenesis. J. Embryol. Exp. Morph. 44, 93-104 (1978).
50. Rossant, J. & McBurney, M. W. The developmental potential of a euploid male teratocarcinoma cell line after blastocyst injection. J. Embryol. Exp. Morph. 70, 99-112 (1982).
51. Blelloch, R. H. et al. Nuclear cloning of embryonal carcinoma cells. Proc. Natl Acad. Sci. USA 101, 13985-13990 (2004).
52. Silver, L. M., Martin, G. R. & Strickland, S. (eds) Teratocarcinoma Stem Cells (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1983).
53. Cole, R. J. & Paul, J. in Ciba Foundation Symposium on Preimplantation Stages of Pregnancy (eds Wolstenholme, G. E. W. & O'Conner, M.) 82-122 (J. & A. Churchill Ltd, 1965).
54. Edwards, R. G. in Handbook of Stem Cells (eds Lanza, R. et al.) 1-14 (Elsevier Academic Press, Burlington, Massachusetts, 2004).
55. Evans, M. J. & Kaufman, M. H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156 (1981).
56. Martin, G. R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl Acad. Sci. USA 78, 7634-7638 (1981).
57. Doetschman, T. C., Eistetter, H., Katz, M., Schmidt, W. & Kemler, R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morph. 87, 27-45 (1985).
58. Williams, R. L. et al. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336, 684-687 (1988).
59. Smith, A. G. et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336, 688-690 (1988).
60. Matsui, Y., Zsebo, K. & Hogan, B. L. M. Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell 70, 841-847 (1992).
61. Resnick, J. L., Bixler, L. S., Cheng, L. & Donovan, P. J. Long-term proliferation of mouse primordial germ cells in culture. Nature 359, 550-551 (1992).
62. Kanatsu-Shinohara, M. et al. Generation of pluripotent stem cells from neonatal mouse testis. Cell 119, 1001-1012 (2004).
63. Hübner, K. et al. Derivation of oocytes from mouse embryonic stem cells. Science 300, 1251-1256 (2003).
64. Toyooka, Y., Tsunekawa, N., Akasu, R. & Noce, T. Embryonic stem cells can form germ cells in vitro. Proc. Natl Acad. Sci. USA 100, 11457-11462 (2003).
65. Geijsen, N. et al. Derivation of embryonic germ cells and male gametes from embryonic stem cells. Nature 427, 148-154 (2004).
66. Bradley, A., Evans, M., Kaufman, M. H. & Robertson, E. Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 309, 255-256 (1984).
67. Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W. & Roder, J. C. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl Acad. Sci. USA 90, 8424-8428 (1993).
68. Gossler, A., Doetschman, T., Korn, R., Serfling, E. & Kemler, R. Transgenesis by means of blastocyst-derived embryonic stem cell lines. Proc. Natl. Acad. Sci. USA 83, 9065-9069 (1986).
69. Robertson, E., Bradley, A., Kuehn, M. & Evans, M. Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature 323, 445-448 (1986).
70. Thomas, K. R. & Capecchi, M. R. Introduction of homologous DNA sequences into mammalian cells induces mutations in the cognate gene. Nature 324, 34-38 (1986).
71. Thomas, K. R., Folger, K. R. & Capecchi, M. R. High frequency targeting of genes to specific sites in the mammalian genome. Cell 44, 419-428 (1986).
72. Kuehn, M. R., Bradley, A., Robertson, E. J. & Evans, M. J. A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature 326, 295-298 (1987).
73. Doetschman, T. et al. Targetted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature 330, 576-578 (1987).
74. Thomas, K. R. & Capecchi, M. R. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51, 503-512 (1987).
75. Thompson, S., Clarke, A. R., Row, A. M., Hooper, M. L. & Melton, D. W. Germ line transmission and expression of a corrected HPRT gene produced by gene targeting in embryonic stem cells. Cell 56, 313-321 (1989).
76. Smithies, O. Many little things: one geneticist's view of complex diseases. Nature Rev. Genet 6, 419-425 (2005).
77. Capecchi, M. R. Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century. Nature Rev. Genet. 6, 507-512 (2005).
78. Ying, Q.-L., Nichols, J., Chambers, I. & Smith, A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115, 281-292 (2003).
79. McBurney, M. W., Jones-Villeneuve, E. M. V., Edwards, M. K. S. & Anderson, P. J. Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line. Nature 299, 165-167 (1982).
80. Wichterle, H., Lieberam, I., Porter, J. A. & Jessell, T. M. Directed differentiation of embryonic stem cells into motor neurons. Cell 110, 385-397 (2002).
81. Kim, J.-H. et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418, 50-56 (2002).
82. Li, H., Roblin, G., Liu, H. & Heller, S. Generation of hair cells by stepwise differentiation of embryonic stem cells. Proc. Natl Acad. Sci. USA 100, 13495-13500 (2003).
83. Schmitt, T. M. et al. Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro. Nature Immunol. 5, 410-417 (2004).
84. Loebel, D. A. F., Watson, C. M., De Young, R. A. & Tam, P. P. L. Lineage choice and differentiation in mouse embryos and embryonic stem cells. Dev. Biol. 264, 1-14 (2003).
85. Conti, L. et al. Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS Biol. 3, 1594-1606 (2005).
86. Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998).
87. Shamblott, M. J. et al. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc. Natl Acad. Sci. USA 95, 13726-13731 (1998).
88. Thomson, J. A. et al. Isolation of a primate embryonic stem cell line. Proc. Natl Acad. Sci. USA 92, 7844-7848 (1995).
89. Amit, M. et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227, 271-278 (2000).
90. Hovatta, O. & Skottman, H. Feeder-free derivation of human embryonic stem-cell lines. Lancet 365, 1601-1603 (2005).
91. Klimanskaya, I. et al. Human embryonic stem cells derived without feeder cells. Lancet 365, 1636-1641 (2005).
92. Xu, R.-H. et al. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nature Methods 2, 185-190 (2005).
93. Schuldiner, M., Yanuka, O., Itskovitz-Eldor, J., Melton, D. A. & Benvenisty, N. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc. Natl Acad. Sci. USA 97, 11307-11312 (2000).
94. Odorico, J. S., Kaufman, D. S. & Thomson, J. A. Multilineage differentiation from human embryonic stem cell lines. Stem Cells 19, 193-204 (2001).
95. Xu, R.-H. et al. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nature Biotechnol. 20, 1261-1264 (2002).
96. Maitra, A. et al. Genomic alterations in cultured human embryonic stem cells. Nature Genet. 37, 1099-1103 (2005).
97. Gardner, R. L. in Handbook of Stem Cells (eds Lanza, R. et al.) 15-26 (Elsevier Academic Press, Burlington, Massachusetts, 2004).
98. Iannaccone, P. M., Taborn, G. U., Garton, R. L., Caplice, M. D. & Brenin, D. R. Pluripotent embryonic stem cells from the rat are capable of producing chimeras. Dev. Biol. 163, 288-292 (1994).
99. Brenin, D., Look, J., Hübner, N., Levan, G. & Iannaccone, P. Correction to: Pluripotent embryonic stem cells from the rat are capable of producing chimeras. Dev. Biol. 185, 124-125 (1997).
100. Bavister, B. D., Wolf, D. P. & Brenner, C. A. Challenges of primate embryonic stem cell research. Cloning Stem Cells 7, 82-94 (2005).
101. Wolf, D. P., Kuo, H.-C., Pau, K.-Y. F. & Lester, L. Progress with nonhuman primate embryonic stem cells. Biol. Reprod. 71, 1766-1771 (2004).
102. Takagi, Y. et al. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J. Clin. Invest. 115, 102-109 (2005).
103. Solter, D. & Gearhart, J. Putting stem cells to work. Science 283, 1468-1470 (1999).
104. Munsie, M. J. et al. Isolation of pluripotent embryonic stem cells from reprogrammed adult somatic cell nuclei. Curr. Biol. 10, 989-992 (2000).
105. Kawase, E., Yamazaki, Y., Yagi, T., Yanagimachi, R. & Pedersen, R. A. Mouse embryonic stem (ES) cell lines established from neuronal cell- derived cloned blastocysts. Genesis 28, 156-163 (2000).
106. Wakayama, T. et al. Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science 292, 740-743 (2001).
107. Hwang, W. S. et al. Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science 303, 1669-1674 (2004).
108. Hwang, W. S. et al. Patient-specific embryonic stem cells derived from human SCNT blastocysts. Science 308, 1777-1783 (2005).
109. Chung, Y. et al. Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres. Nature 439, 216-219 (2005).
110. Meissner, A. & Jaenisch, R. Generation of nuclear transfer-derived pluripotent ES cells from cloned Cdx2-deficient blastocysts. Nature 439, 212-215 (2005).
111. Solter, D. Politically correct human embryonic stem cells? N. Engl. J. Med. 353, 2321-2323 (2005).
112. Simonsson, S. & Gurdon, J. DNA demethylation is necessary for the epigenetic reprogramming of somatic cell nuclei. Nature Cell Biol. 6, 984-990 (2004).
113. Sullivan, E. J., Kasinathan, S., Kasinathan, P., Robl, J. M. & Collas, P. Cloned calves from chromatin remodeled in vitro. Biol. Reprod. 70, 146-153 (2004).
114. Park, K.-S. et al. Phenotypic alteration of eukaryotic cells using randomized libraries of artificial transcription factors. Nature Biotechnol. 21, 1208-1214 (2003).
115. Ding, S. et al. Synthetic small molecules that control stem cell fate. Proc. Natl Acad. Sci. USA 100, 7632-7637 (2003).
116. Ding, S. & Schultz, P. G. A role for chemistry in stem cell biology. Nature Biotechnol. 22, 833-840 (2004).
117. Anderson, D. G., Levenberg, S. & Langer, R. Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells. Nature Biotechnol. 22, 863-866 (2004).
118. Boyer, L. A. et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122, 947-956 (2005).